Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4+Foxp3+ Treg Induction
Authors:
- Magdalena MassalskaMMMagdalena Massalska
- Marzena CiechomskaMCMarzena Ciechomska
- Ewa Kuca-WarnawinEKEwa Kuca-Warnawin
- Anna RadzikowskaARAnna Radzikowska
- Dariusz PawlakDariusz Pawlak
- Barbara MuzBarbara Muz
- Adrianna Loniewska-LwowskaALAdrianna Loniewska-Lwowska
- Pawel MaldykPMPawel Maldyk
- Wlodzimierz MaslinskiWMWlodzimierz Maslinski
Open Access
- 22 December 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 6813-6829
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease with systemic inflammation finally resulting in damaged joints. One of the RA development models suggests bone marrow (BM) as a place of inflammation development further leading to disease progression. We aimed to investigate the potential of CTLA-4-Fc molecule in inducing tolerogenic milieu in BM measured as indoleamine 2,3-dioxygenase (IDO) expression, CD4+Foxp3+ Treg induction, and T cell activation control. The expression of IDO-pathway genes was also examined in monocytes to estimate the tolerogenic potential in the periphery. Methods: Bone marrow mononuclear cells (BMMC) were stimulated by pro-inflammatory cytokines and CTLA-4-Fc. Next IDO expression, CD4+CD69+ and CD4+Foxp3+ percentage were estimated by PCR and FACS staining, respectively. Enzymatic activity of IDO was confirmed by HPLC in BM plasma and blood plasma. Genes expressed in IDO-pathway were analyzed by NGS in peripheral monocytes isolated from RA patients and healthy controls. Results: We found that CTLA-4-Fc and IFN-γ stimulation results in IDO production by BMMC. CTLA-4-Fc induced tryptophan catabolism can inhibit mitogen-induced CD4+ T cells activation without influencing CD8+ cells, but did not control CD25 nor Foxp3 expression in BM cells. Significantly higher expression of selected IDO-pathway genes was detected on peripheral monocytes isolated from RA as compared to healthy controls. Conclusion: This study sheds light on some immunosuppression aspects present or induced in BM. The potential of IDO-mediated pathways were confirmed in the periphery, what may represent the promising candidates for therapeutic strategies in RA.Keywords
This publication has 57 references indexed in Scilit:
- Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15?Annals of the Rheumatic Diseases, 2011
- Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in miceArthritis Research & Therapy, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- Bone Marrow Retaining Colitogenic CD4+ T Cells May Be a Pathogenic Reservoir for Chronic ColitisGastroenterology, 2007
- Tryptophan degradation increases with stage in patients with rheumatoid arthritisClinical Rheumatology, 2005
- Dendritic cells: potential triggers of autoimmunity and targets for therapyAnnals of the Rheumatic Diseases, 2005
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseJournal of Experimental Medicine, 2002
- Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsJournal of Experimental Medicine, 2002
- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis & Rheumatism, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988